Robert Di Tullio, ProteoGenix Vice President, Regulatory Affairs & Quality, will be participating in a September 17 forum sponsored by the California Healthcare Institute entitled
"Keeping Pace with Technology: Molecular Diagnostics Regulation and Reimbursement"

8/26/2008 - Robert Di Tullio, ProteoGenix Vice President, Regulatory Affairs & Quality, will be participating in a forum sponsored by the California Healthcare Institute entitled “Keeping Pace with Technology: Molecular Diagnostics Regulation and Reimbursement”. Mr. Di Tullio will be participating in a moderated panel discussion and question and answer session focused on “Emerging Regulatory Trends”.

This forum is scheduled to be held on Wednesday, September 17 from 11:00 AM to 6:00 PM at Gen-Probe Incorporated, 10210 Genetic Center Drive San Diego, California 92121.

The California Healthcare Institute (CHI) was founded in 1993 as an independent organization devoted to researching and advocating policy to forward the interests of California’s biomedical community. More information about this forum is available at http://chi.org/basicpage.aspx?id=4534 or by contacting CHI Corporate Headquarters at 1020 Prospect St, Suite 310, La Jolla, CA 92037 TEL.858.551.6677